In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the human motor system. Subunits of the 33-amino acid containing motorneurontrophic factor (MNTF) have been investigated and GM6 has been found as a potential peptide therapeutic for ALS. This linear peptide dru...
Saved in:
Main Authors: | Klara Livia Valko (Author), Mark Kindy (Author), James Evans (Author), Dororhy Ko (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide therapeutics
by: Klara Livia Valko, et al.
Published: (2018) -
Amyotrophic Lateral Sclerosis
Published: (2012) -
Amyotrophic Lateral Sclerosis
Published: (2021) -
Update on Amyotrophic Lateral Sclerosis
Published: (2016) -
Kinesitherapy in amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2017)